- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Janssen Inc.
Total 38405 results
-
Janssen-Cilag Ltd.CompletedChild Behavior Disorders | Learning Disorders
-
Janssen-Cilag, S.A.TerminatedGastroesophageal Reflux | Gastric Ulcer
-
Janssen-Cilag, S.A.TerminatedSchizophrenia | Schizoaffective Disorder | Schizophreniform Disorders
-
Janssen Pharmaceutical K.K.CompletedOsteoarthritis | Low Back Pain
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen-Cilag S.p.A.CompletedMental Disorders | Brain Diseases | Dementia | Alzheimer Disease
-
Jonsson Comprehensive Cancer CenterViewray Inc.Active, not recruitingPSA Progression | Stage III Prostate Adenocarcinoma AJCC v7 | Stage II Prostate Adenocarcinoma AJCC v7 | PSA Level Greater Than 0.03 | Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7United States
-
Jonsson Comprehensive Cancer CenterImaginAb, Inc.CompletedPancreatic Cancer | Prostate Cancer | Bladder CancerUnited States
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.CompletedGlioblastoma | Gliosarcoma | Giant Cell GlioblastomaUnited States
-
Scott C. Woller, MDJanssen PharmaceuticalsNot yet recruitingDeep Vein Thrombosis | Hospitalism | Venous Thromboembolic Disease | Pulmonary Embolism and ThrombosisUnited States
-
University of British ColumbiaUniversity Health Network, Toronto; Janssen Inc.RecruitingGenomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer (GUNS)Prostate CancerCanada, United States
-
Memorial Sloan Kettering Cancer CenterPharmacyclics LLC.; Janssen Biotech, Inc.RecruitingAdult Patients With Newly Diagnosed or Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL) | Or Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)United States
-
Scripps Translational Science InstituteJanssen Scientific Affairs, LLC; Aetna, Inc.Completed
-
McMaster UniversityHamilton Health Sciences Corporation; Janssen-Ortho Inc., CanadaTerminated
-
McMaster UniversityHamilton Health Sciences Corporation; Janssen-Ortho Inc., CanadaCompletedEfficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD)Obsessive Compulsive DisorderCanada
-
Bristol-Myers SquibbNovartis; Clovis Oncology, Inc.; Janssen Pharmaceuticals; ExelixisRecruitingCancerUnited States, Israel, Spain, Italy, Germany, Australia, Belgium, China, Korea, Republic of, Greece, Japan, Argentina, Austria, Brazil, Canada, Chile, Denmark, Finland, France, Hungary, Ireland, Mexico, Netherlands, Poland, Russian Federation and more
-
Associated Scientists to Help Minimize AllergiesEisai Inc.; Janssen PharmaceuticalsCompletedAsthma | Gastroesophageal Reflux DiseaseUnited States
-
Janssen Research & Development, LLCNot yet recruitingRelapsed or Refractory Multiple Myeloma
-
Janssen Research & Development, LLCRecruitingAdvanced Stage Solid TumorsSpain
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaGermany, Korea, Republic of, Italy, France, Japan, Israel, Belgium, Denmark, Sweden, China, Spain, Czechia, Poland, Australia, Netherlands, Argentina, Canada, United Kingdom, Greece, Brazil, India
-
Janssen Research & Development, LLCRecruiting
-
Janssen Research & Development, LLCRecruitingColitis, UlcerativeKorea, Republic of, Canada, United States, Australia, Czechia, Malaysia, Germany, Turkey, Japan, Belgium, Hungary, Italy, Spain, China, Poland, United Kingdom, Brazil, France, Argentina, Romania, India
-
Janssen Research & Development, LLCRecruitingModerate Plaque PsoriasisUnited States, Canada
-
Janssen Research & Development, LLCRecruitingCrohn's DiseasePoland, United States, Japan, Spain, Norway
-
Janssen Research & Development, LLCRecruitingDepressive Disorder, MajorUnited States, Korea, Republic of, Spain, Argentina, United Kingdom, Sweden, Italy, Germany, France, Canada, Brazil
-
Janssen Research & Development, LLCRecruitingMetastatic Castration-resistant Prostate NeoplasmsUnited States, Australia
-
Janssen Research & Development, LLCRecruitingBladder CancerUnited States, Belgium, Korea, Republic of, Italy, Taiwan, China, United Kingdom, Germany, France, Argentina, Brazil, Poland, Spain, Czechia, Japan, Netherlands, India, Canada, Mexico, Australia, Portugal
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple Myeloma | Previously Treated Amyloid Light-chain (AL) AmyloidosisBelgium, United States, United Kingdom, Spain, France, Netherlands
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaBelgium, Korea, Republic of, Australia, United Kingdom, France, Sweden, Spain, Turkey, Italy, Czechia, Netherlands, Poland, Switzerland, Germany
-
Janssen Research & Development, LLCRecruitingAnhedonia | Depressive Disorder, MajorKorea, Republic of, United States, China, Taiwan, Slovakia, Brazil, Poland, Argentina, Bulgaria, Czechia, South Africa, Canada, United Kingdom, France
-
Janssen Research & Development, LLCNot yet recruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage | Acute LeukemiasUnited States
-
Janssen Research & Development, LLCRecruitingDepressive Disorder, MajorUnited States, Korea, Republic of, Taiwan, Slovakia, Spain, Bulgaria, Poland, Belgium, Argentina, Czechia, Hungary, South Africa, Sweden, Italy, France, Australia, China, Brazil, Portugal
-
Janssen Research & Development, LLCRecruitingLymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-CellUnited States, China, France, Denmark, Israel, Poland, Australia
-
Janssen Research & Development, LLCRecruitingAdvanced or Metastatic Colorectal CancerUnited States, Korea, Republic of, Taiwan, Malaysia, Germany, Italy, Spain, Belgium, Canada, Puerto Rico, China
-
Janssen Research & Development, LLCRecruitingAmyloidosisCanada, Italy, United States, Greece, China, Netherlands, Spain, France, Germany, United Kingdom
-
Janssen Research & Development, LLCRecruitingCrohn's DiseaseUnited States, Denmark, Belgium, Taiwan, Italy, Korea, Republic of, Germany, United Kingdom, Israel, Malaysia, Poland, Japan, New Zealand, Netherlands, China, Canada, France, Spain, Norway, Singapore, Croatia, Brazil, Switzerland, Aus... and more
-
Janssen Research & Development, LLCRecruitingDengueMexico, Malaysia, Brazil, Colombia, Puerto Rico, Panama, Peru, Philippines, Thailand
-
Janssen Pharmaceutica N.V., BelgiumRecruitingRelapsed/Refractory Multiple MyelomaGermany, Italy, Belgium, Spain, Netherlands, France, United Kingdom
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Belgium, United Kingdom, Netherlands, France, Australia
-
Janssen Research & Development, LLCRecruitingUrinary Bladder NeoplasmsUnited States, Korea, Republic of, France, Israel, Spain, Italy, United Kingdom, Belgium, Netherlands, Germany
-
Janssen Research & Development, LLCNot yet recruitingLupus NephritisUnited States
-
Janssen Research & Development, LLCRecruitingHematological MalignanciesUnited States, Belgium, Korea, Republic of, China, Germany, Israel, Netherlands, Japan, Spain, France, Poland
-
Janssen Research & Development, LLCRecruitingHepatic ImpairmentUnited States
-
Janssen Research & Development, LLCRecruitingWarm Autoimmune Hemolytic AnemiaUnited States, Israel, Korea, Republic of, Spain, Czechia, France, Brazil, China, United Kingdom, Malaysia, Hungary, Japan, Poland, Germany, Ukraine, Italy, Greece, Netherlands, Egypt
-
Janssen Research & Development, LLCRecruitingCarcinoma, Non-Small-Cell LungTaiwan, United States, Korea, Republic of, Germany, France, China, Japan, Italy, Spain, Puerto Rico
-
Janssen Research & Development, LLCRecruitingMultidrug-Resistant TuberculosisMozambique, Philippines, Russian Federation, South Africa, Uganda, Ukraine
-
Janssen Research & Development, LLCActive, not recruitingCrohn DiseaseBelgium, United States, Japan, Czechia, Hungary, Korea, Republic of, France, Taiwan, Germany, Malaysia, New Zealand, Poland, Canada, Turkey, Croatia, Israel, China, Denmark, Netherlands, Brazil, Italy, Spain, Jordan, Bosnia and Herzegovina and more